Sorted by date Results 1 - 1 of 1
"Everyday low prices" are coming to health care. Walmart recently launched its own analog insulin, a synthetic form of the hormone that's genetically modified to be released rapidly or slowly, depending on a person's needs. It will be manufactured by pharmaceutical giant Novo Nordisk — but cost 75% less than brand-name analog insulin. The deal stands out as proof that markets can deliver outcomes that work for producers and consumers alike — if we let them. Generally speaking, the "market" for medicines is dysfunctional. It bears little res... Full story